Gene-Edited Crops Industry Outlook: Precision breeding and climate-resilient agriculture reshape global crop innovation through 2036

Industry Overview

The global Gene-Edited Crops market is gaining momentum as agricultural biotechnology companies, seed developers, research institutions, and food producers adopt precision breeding technologies to improve crop performance and address agricultural challenges. Gene editing uses tools such as CRISPR-Cas systems, TALENs, and other targeted molecular techniques to introduce specific genetic changes in plants, including modifications to genes associated with disease resistance, drought tolerance, yield, nutritional quality, and shelf life. Unlike conventional genetic modification approaches that may introduce foreign genetic material, some gene-editing methods can produce targeted changes without retaining DNA from another species. Demand is increasing as climate change, crop losses, food security concerns, and the need for sustainable agricultural productivity encourage faster crop improvement. Commercial development is advancing across soybean, maize, rice, wheat, tomato, potato, and specialty crops, supported by improvements in genome sequencing, bioinformatics, plant transformation, and regulatory clarity in selected markets.

Industry Insights: Scale, Segments, and Shifts

Market Size & Growth: The Gene-Edited Crops market is an emerging segment within the broader agricultural biotechnology and genome-editing markets. Published market estimates frequently combine crop gene editing with wider plant biotechnology, CRISPR applications, or agricultural genome-editing services, making a single standalone global revenue figure difficult to compare consistently. The commercial opportunity is expanding through the development of gene-edited seeds, crop traits, breeding platforms, and licensing arrangements. Growth is supported by demand for climate-resilient varieties, disease-resistant crops, improved nutrient profiles, reduced food waste, and faster breeding cycles. Gene editing can shorten the time required to develop selected traits compared with conventional breeding alone, although field validation, regulatory review, seed multiplication, and farmer adoption remain important stages before commercial scale is achieved. Through 2036, the industry is expected to benefit from broader deployment of precision breeding technologies and increasing investment in agricultural innovation.

Segment Analysis: CRISPR-Cas technologies represent a major platform for gene-edited crop development because they enable targeted modifications to selected plant genes. Other approaches include TALENs, zinc-finger nucleases, and emerging editing systems that support different levels of precision and modification. By crop type, development activity includes soybean, maize, rice, wheat, tomato, potato, canola, cotton, and specialty crops. Soybean and maize are important targets because of their large cultivation areas and commercial value, while rice and wheat are significant for food security and climate adaptation. By trait, key development areas include herbicide tolerance, disease resistance, insect resistance, drought and heat tolerance, improved yield, nutritional enhancement, oil composition, reduced browning, and extended shelf life. By application, gene-edited crops are being developed for food production, animal feed, industrial processing, biofuel feedstocks, and specialty agricultural products. Commercialization models include seed sales, trait licensing, technology partnerships, and collaborations between biotechnology companies and established seed producers.

Regional Highlights: North America holds approximately 38% of the global market share in 2025, supported by advanced agricultural biotechnology infrastructure, strong investments in CRISPR-based crop development, favorable regulatory pathways for certain gene-edited plants, and growing demand for climate-resilient and high-yield crop varieties across the United States and Canada. Asia Pacific continues to witness strong growth driven by government-backed agricultural biotechnology programs, food security initiatives, and increasing research into drought-tolerant, disease-resistant, and nutrient-enhanced crops across China, Japan, India, and Australia, while Europe is emphasizing sustainable crop innovation, biodiversity protection, and evolving regulatory frameworks for new genomic techniques.

Competitive Landscape: Competition involves agricultural biotechnology developers, seed companies, genome-editing platform providers, research institutions, and technology licensors. Companies compete through editing accuracy, trait performance, crop transformation capabilities, breeding speed, intellectual property portfolios, regulatory expertise, and partnerships with commercial seed distributors. Strategic activity includes licensing CRISPR technologies, acquiring or collaborating with specialist breeding companies, developing proprietary editing platforms, and combining gene editing with genomic selection and advanced phenotyping. Companies that can demonstrate stable field performance, measurable farmer benefits, and regulatory compliance are positioned to improve commercialization prospects.

Factors Shaping the Next Decade

Market Gaps / Restraints: Regulatory uncertainty, lengthy field-testing requirements, intellectual property restrictions, and limited public familiarity remain important barriers to the Gene-Edited Crops industry. Requirements differ across countries depending on the editing technique, type of genetic modification, presence of foreign DNA, and intended use. Developers may need to complete molecular characterization, food and feed safety assessments, environmental evaluations, and multi-location field trials before commercial release. Crop transformation and regeneration can also be technically difficult, particularly in certain legumes and locally important crops. Small and medium-sized breeding companies may face high research, licensing, and regulatory costs. 

Key Trends and Innovations: Major trends include CRISPR-Cas9 and CRISPR-Cas12a editing, base editing, prime editing, multiplex gene editing, and the integration of genome editing with genomic selection. Developers are targeting genes associated with disease resistance, insect resistance, herbicide tolerance, heat stress, drought response, nutrient composition, and crop quality. Multiplex editing allows researchers to modify multiple genetic targets in a single development program, which may help address complex agronomic traits. Base and prime editing are expanding the range of possible genetic changes, including precise nucleotide substitutions. 

Potential Opportunities: Significant opportunities exist in climate-resilient seeds, disease-resistant staple crops, nutritional improvement, and specialty crop development. Gene-edited rice, wheat, maize, soybean, millets, pulses, and oilseeds can support agricultural productivity and food security, particularly in regions facing heat stress, drought, salinity, and emerging crop diseases. Specialty crops such as tomato, potato, lettuce, strawberry, and leafy vegetables offer opportunities for traits that directly benefit consumers and food processors. Developers can also pursue reduced post-harvest losses, improved processing characteristics, healthier oil profiles, and longer product shelf life. Public-private research partnerships and humanitarian licensing arrangements can expand access to gene-editing tools for crops important to smallholder farmers. 

Recent Industry Updates

• September 2026: ICRISAT's access to the CRISPR-Cas9 patent portfolio through a licensing arrangement with Corteva Agriscience and the Broad Institute was highlighted as a major development for crop improvement. The agreement supports research into climate-resilient and higher-yielding pulses, millets, oilseeds, chickpea, pigeon pea, and groundnut for smallholder farming systems in Asia and Africa. 

• July 2026: Pairwise participated in an FDA premarket meeting concerning gene-edited blackberry. The proposed traits include compact plant architecture, earlier flowering, reduced stem prickles, and reduced seed lignification, illustrating the expansion of gene editing into specialty fruit crops.

• February 2026: The U.S. Food and Drug Administration recorded a premarket meeting concerning gene-edited romaine lettuce developed for reduced browning. The product, associated with GreenVenus LLC, demonstrates continued development of gene-edited vegetables with food-quality benefits.

• December 2025: China's agricultural biotechnology developments included approval of the first gene-edited rice event for local cultivation, according to a USDA Foreign Agricultural Service report. The development represents an important regulatory milestone for gene-edited crop commercialization in the country. 

Industry Outlook Scope

By Editing Technology

• CRISPR-Based Gene Editing

• Base Editing

• TALEN-Based Gene Editing

• Zinc Finger Nucleases

• Oligonucleotide-Directed Mutagenesis

• Other Genome Editing Technologies

By Crop Type

• Cereals and Grains

• Oilseeds

• Fruits and Vegetables

• Pulses and Legumes

• Fiber and Industrial Crops

• Other Specialty Crops

By Editing Outcome

• Single-Gene Modification

• Multi-Gene Modification

• Gene Knockout

• Gene Insertion or Replacement

• Gene Regulation Modification

• Base Substitution

• Other Targeted Genetic Modifications

By Regulatory Category

• SDN-1-Based Gene Editing

• SDN-2-Based Gene Editing

• SDN-3-Based Gene Editing

• Cisgenic and Intragenic Modifications

• Other Precision-Breeding Categories

By Application

• Food Crops

• Animal Feed Production

• Industrial Crop Production

• Biofuel and Bioenergy Feedstocks

• Food Processing and Ingredient Manufacturing

• Other Applications

By End User

• Commercial Seed Companies

• Agricultural Biotechnology Companies

• Crop Research Institutes

• Universities and Public Research Organizations

• Farmers and Agricultural Cooperatives

• Food and Feed Processing Companies

• Other End Users

By Commercialization Model

• Gene-Edited Seed Sales

• Trait Licensing

• Genome-Editing Technology Licensing

• Research and Development Partnerships

• Contract Editing and Breeding Services

• Other Commercialization Models

By Region

• North America

o U.S.

o Canada

o Mexico

• Europe

o UK

o Italy

o Spain

o Germany

o France

o BENELUX

o Nordics

o Rest of Europe

• Asia Pacific

o China

o India

o Japan

o South Korea

o Southeast Asia

o Australia & New Zealand

• Middle East & Africa

o Saudi Arabia

o Other GCC

o South Africa

o Rest of Middle East & Africa

• South America

o Brazil

o Chile

o Argentina

o Rest of South America

Geographical Insights: Regulatory Progress and Agricultural Biotechnology Investment Shape Regional Adoption

Regional Overview: North America benefits from established agricultural biotechnology companies, university research networks, advanced seed development capabilities, and established regulatory consultation pathways. The United States is a major center for gene-edited crop development, with commercial and premarket activity involving soybean, maize, potato, lettuce, and specialty crops. Canada also has experience with plant varieties developed through newer breeding techniques. Asia Pacific is an important growth region as China advances agricultural biotechnology research and India expands gene-editing research for climate-resilient cereals, pulses, and oilseeds. Japan has developed a commercial pathway for selected gene-edited food products, including high-GABA tomato. Europe has strong plant genomics and crop science capabilities, although regulatory requirements and public acceptance influence the speed of commercialization.

Countries to Watch: The United States, China, India, Japan, Canada, the United Kingdom, Brazil, Argentina, Australia, and the Philippines are important markets to monitor. The United States has active commercial development and regulatory consultations for gene-edited crops. China is advancing agricultural biotechnology research and has taken steps toward cultivation of gene-edited varieties. India offers significant opportunities in rice, pulses, millets, oilseeds, and other crops relevant to smallholder agriculture. Japan is an important market for consumer-facing gene-edited food products. The United Kingdom has established a precision-breeding framework for qualifying organisms in England, while Canada has experience with plants developed through newer breeding techniques. Brazil and Argentina offer opportunities through their large agricultural seed markets and crop research ecosystems. Australia and the Philippines are relevant markets for agricultural biotechnology research and regulatory development.

Regulatory Environment and Policy Support

Government Regulations & Supportive Policies: The Gene-Edited Crops industry is influenced by biosafety regulations, food and feed safety requirements, environmental assessment procedures, seed certification rules, intellectual property rights, and national policies governing new breeding techniques. Regulatory treatment varies according to the type of genetic change, whether foreign genetic material remains in the final plant, and the intended use of the crop. In the United States, the USDA's SECURE Rule provides a framework for determining whether certain modified plants are subject to regulation under its biotechnology regulations. The FDA provides voluntary premarket consultation for foods from genome-edited plants, while the Environmental Protection Agency regulates relevant plant-incorporated protectants where applicable. In the European Union, the regulatory framework for genetically modified organisms has historically applied to many genome-edited plants, while proposed and evolving New Genomic Techniques rules seek to establish differentiated treatment for certain categories of plants. In England, the Genetic Technology (Precision Breeding) Act 2023 and associated regulations provide a separate framework for qualifying precision-bred organisms. 

Key Government Initiatives: Governments and public research institutions are supporting gene-edited crop development through agricultural biotechnology programs, public-private research partnerships, crop improvement missions, and investment in genomic research infrastructure. India's Department of Biotechnology and agricultural research institutions are advancing genome-editing research for crops relevant to food security and climate resilience. ICAR and affiliated research centers are involved in evaluating improved crop varieties, while ICRISAT's CRISPR-Cas9 licensing arrangement with Corteva and the Broad Institute creates additional research opportunities for pulses, millets, and oilseeds. China's agricultural biotechnology initiatives focus on improving crop productivity, disease resistance, and domestic food security. Japan's regulatory and research environment has supported the development and market introduction of selected gene-edited food products. 

Competitive Landscape and Strategic Outlook

The Gene-Edited Crops industry is moving from laboratory-focused research toward commercial trait development, regulatory review, field validation, and seed-market integration. CRISPR-based technologies are expected to remain important, while base editing, prime editing, and multiplex gene editing expand the range of genetic modifications available to crop developers. Companies are increasingly targeting traits that offer measurable benefits to farmers and food producers, including disease resistance, yield improvement, climate resilience, nutritional enhancement, and reduced post-harvest losses. Partnerships between genome-editing platform owners, seed companies, universities, and public research institutes are helping distribute development costs and expand access to intellectual property. Through 2036, competitive advantage will depend on editing precision, crop transformation expertise, trait stability, regulatory readiness, field performance, and commercial seed distribution. Companies that can translate genetic improvements into reliable varieties suited to local farming conditions are positioned to strengthen their market presence.

Industry Competition

• Bayer AG

• Corteva Agriscience

• Syngenta Group

• BASF SE

• Pairwise

• Inari Agriculture

• Cibus, Inc.

• Tropic Biosciences

• J.R. Simplot Company

• Yield10 Bioscience

• Hudson River Biotechnology

• KeyGene

• Benson Hill

• Rijk Zwaan

• KWS SAAT SE & Co. KGaA

• Sakata Seed Corporation

• Takii & Co., Ltd.

• ICRISAT

• International Rice Research Institute (IRRI)

Analyst Perspective

The Gene-Edited Crops industry is becoming an important component of next-generation agricultural biotechnology as food producers seek crop varieties that can withstand climate stress, resist diseases, improve nutritional quality, and reduce production losses. CRISPR-based editing is creating opportunities to develop targeted crop traits with greater precision, while base editing, prime editing, and multiplex approaches are expanding the technological possibilities. Demand is likely to develop across staple crops, oilseeds, pulses, fruits, and vegetables, with specialty crops offering additional opportunities through consumer-focused quality improvements. However, regulatory differences, intellectual property access, complex trait development, field validation, and public acceptance will continue to influence commercialization. Through 2036, the industry's progress will depend on the ability of biotechnology developers and seed companies to demonstrate stable agronomic performance, affordable seed access, and clear benefits for farmers and food supply chains.

What to Expect from Outlook

1. Save time carrying out entry-level research by identifying market size, growth, crop types, editing technologies, trait categories, applications, commercialization models, leading companies, and regional opportunities.

2. Use PORTER’s Five Forces analysis to assess competitive intensity, supplier and buyer power, substitution risks, barriers to entry, intellectual property control, regulatory requirements, and the influence of seed distribution networks on industry competition.

3. Profiles of leading companies provide insights into regional operations, strategies, financials, research pipelines, genome-editing platforms, crop portfolios, licensing arrangements, partnerships, and commercialization initiatives.

4. Add weight to presentations and pitches with a decade forecast by market share (%) and revenue (USD Billion), supporting strategic planning and competitive positioning.

Frequently Asked Questions (FAQs)

Q1. What is the size of the Gene-Edited Crops industry in 2026?

Answer: The global Gene-Edited Crops industry is estimated at approximately USD 3.08 billion in 2026, according to a published estimate for the gene-editing in crops market. Demand is supported by the development of CRISPR-based crop varieties, improved seed traits, climate-resilient agriculture, and precision breeding technologies.

Q2. What is the projected size of the Gene-Edited Crops industry by 2036?

Answer: The Gene-Edited Crops industry could reach approximately USD 9.44 billion by 2036, based on an illustrative extension of the 11.85% CAGR reported for 2026–2032. This calculation applies the reported growth rate to the 2026 estimate of USD 3.08 billion for ten years. It is a calculated projection rather than a separately published 2036 forecast.

Q3. Which segment leads the Gene-Edited Crops industry?

Answer: CRISPR-based technologies represent a major editing platform, while cereals and grains, oilseeds, and specialty crops are important development categories. Soybean, maize, rice, and wheat are key targets because of their agricultural scale, food security importance, and commercial potential. A definitive leading segment by revenue depends on the market segmentation and methodology used by individual research publishers.

Q4. Which region dominates the Gene-Edited Crops industry?

Answer: North America is an important region for gene-edited crop research and commercialization, supported by established agricultural biotechnology companies, seed developers, research institutions, and regulatory consultation pathways. Asia Pacific is also a significant growth region due to agricultural biotechnology investment in China, India, and Japan.

Q5. What are the major trends shaping the Gene-Edited Crops industry through 2036?

Answer: Major trends include CRISPR-Cas9 and CRISPR-Cas12a editing, base editing, prime editing, multiplex gene modification, climate-resilient crop development, disease resistance, nutritional enhancement, reduced post-harvest losses, advanced genomic selection, and partnerships between biotechnology developers and seed companies.